Cell Growth & Differentiation, Vol 1, Issue 1 3-7, Copyright © 1990 by American Association of Cancer Research

ARTICLES

Identification of autophosphorylation sites of HER2/neu

R Hazan, B Margolis, M Dombalagian, A Ullrich, A Zilberstein and J Schlessinger
Rorer Biotechnology, Inc., King of Prussia, Pennsylvania 19406.

HER2 or c-erbB-2 is a putative growth factor receptor with sequence homology to the epidermal growth factor receptor. It is the human homologue of the rat protooncogene neu and may have an important role in human malignancies such as breast and ovarian cancers. Like other growth factor receptors, HER2 has intrinsic protein tyrosine kinase activity and undergoes autophosphorylation. Recently, we have demonstrated that, similar to the epidermal growth factor receptor, all autophosphorylation sites of HER2 are localized in the carboxyl terminus of this protein. In the present study, immunopurified HER2 was allowed to autophosphorylate, and tryptic phosphopeptides were generated. After purification of these phosphopeptides by high performance liquid chromatography, microsequencing was performed. Utilizing this approach, two autophosphorylation sites were unequivocally identified at Y1023 and Y1248. The sequences of two other tyrosine phosphorylated tryptic peptides were determined, but the exact site of autophosphorylation could not be determined because multiple tyrosines were located on each peptide. However, each of these peptides contains tyrosines that correspond to major autophosphorylation sites of the epidermal growth factor receptor, suggesting that, in addition to Y1023 and Y1248, Y1139 and Y1222 also serve as autophosphorylation sites of HER2.

This article has been cited by other articles:

				J. J. Northey, J. Chmielecki, E. Ngan, C. Russo, M. G. Annis, W. J. Muller, and P. M. Siegel Signaling through ShcA Is Required for Transforming Growth Factor {beta}- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion Mol. Cell. Biol., May 15, 2008; 28(10): 3162 - 3176. [Abstract] [Full Text] [PDF]

				S. L. Emanuel, T. V. Hughes, M. Adams, C. A. Rugg, A. Fuentes-Pesquera, P. J. Connolly, N. Pandey, S. Moreno-Mazza, J. Butler, V. Borowski, et al. Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors Mol. Pharmacol., February 1, 2008; 73(2): 338 - 348. [Abstract] [Full Text] [PDF]

				Y. Zhou and M. G. Brattain Synergy of Epidermal Growth Factor Receptor Kinase Inhibitor AG1478 and ErbB2 Kinase Inhibitor AG879 in Human Colon Carcinoma Cells Is Associated with Induction of Apoptosis Cancer Res., July 1, 2005; 65(13): 5848 - 5856. [Abstract] [Full Text] [PDF]

				K.-P. Xu, A. Riggs, Y. Ding, and F.-S. X. Yu Role of ErbB2 in Corneal Epithelial Wound Healing Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4277 - 4283. [Abstract] [Full Text] [PDF]

				R. Chan, W. R. Hardy, D. Dankort, M. A. Laing, and W. J. Muller Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development Development, November 15, 2004; 131(22): 5551 - 5560. [Abstract] [Full Text] [PDF]

				J. M. Swiercz, R. Kuner, and S. Offermanns Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2 J. Cell Biol., June 21, 2004; 165(6): 869 - 880. [Abstract] [Full Text] [PDF]

				S.-O. Kim, J. C. D. Houtman, J. Jiang, J. M. Ruppert, P. J. Bertics, and S. J. Frank Growth Hormone-induced Alteration in ErbB-2 Phosphorylation Status in 3T3-F442A Fibroblasts J. Biol. Chem., December 10, 1999; 274(50): 36015 - 36024. [Abstract] [Full Text] [PDF]

				P. W. Janes, M. Lackmann, W. B. Church, G. M. Sanderson, R. L. Sutherland, and R. J. Daly Structural Determinants of the Interaction between the erbB2 Receptor and the Src Homology 2Domain of Grb7 J. Biol. Chem., March 28, 1997; 272(13): 8490 - 8497. [Abstract] [Full Text] [PDF]

				W. Kavanaugh, C. Turck, and L. Williams PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine Science, May 26, 1995; 268(5214): 1177 - 1179. [Abstract] [PDF]

				O. Tikhomirov and G. Carpenter Caspase-dependent Cleavage of ErbB-2 by Geldanamycin and Staurosporin J. Biol. Chem., August 31, 2001; 276(36): 33675 - 33680. [Abstract] [Full Text] [PDF]